vs

Side-by-side financial comparison of Viridian Therapeutics, Inc.\DE (VRDN) and Xperi Inc. (XPER). Click either name above to swap in a different company.

Xperi Inc. is the larger business by last-quarter revenue ($116.5M vs $70.6M, roughly 1.7× Viridian Therapeutics, Inc.\DE). Xperi Inc. runs the higher net margin — -14.7% vs -49.0%, a 34.4% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -4.8%). Xperi Inc. produced more free cash flow last quarter ($1.2M vs $-84.7M).

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

Xperi Inc. is an American multinational technology company headquartered in San Jose, California, that develops software for consumer electronics and connected cars, as well as media platforms for video service over broadband. The company is organized into four business units: Pay TV, Consumer Electronics, Connected Car, and Media Platform. Xperi's brands include DTS, HD Radio, and TiVo.

VRDN vs XPER — Head-to-Head

Bigger by revenue
XPER
XPER
1.7× larger
XPER
$116.5M
$70.6M
VRDN
Growing faster (revenue YoY)
VRDN
VRDN
+81962.9% gap
VRDN
81958.1%
-4.8%
XPER
Higher net margin
XPER
XPER
34.4% more per $
XPER
-14.7%
-49.0%
VRDN
More free cash flow
XPER
XPER
$85.9M more FCF
XPER
$1.2M
$-84.7M
VRDN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
VRDN
VRDN
XPER
XPER
Revenue
$70.6M
$116.5M
Net Profit
$-34.6M
$-17.1M
Gross Margin
Operating Margin
-56.7%
-12.7%
Net Margin
-49.0%
-14.7%
Revenue YoY
81958.1%
-4.8%
Net Profit YoY
54.9%
-137.0%
EPS (diluted)
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VRDN
VRDN
XPER
XPER
Q4 25
$116.5M
Q3 25
$70.6M
$111.6M
Q2 25
$105.9M
Q1 25
$114.0M
Q4 24
$122.4M
Q3 24
$132.9M
Q2 24
$119.6M
Q1 24
$118.8M
Net Profit
VRDN
VRDN
XPER
XPER
Q4 25
$-17.1M
Q3 25
$-34.6M
$-6.1M
Q2 25
$-14.8M
Q1 25
$-18.4M
Q4 24
$46.2M
Q3 24
$-16.8M
Q2 24
$-30.3M
Q1 24
$-13.1M
Operating Margin
VRDN
VRDN
XPER
XPER
Q4 25
-12.7%
Q3 25
-56.7%
-1.2%
Q2 25
-10.5%
Q1 25
-14.4%
Q4 24
-11.7%
Q3 24
-14.0%
Q2 24
-18.3%
Q1 24
-27.2%
Net Margin
VRDN
VRDN
XPER
XPER
Q4 25
-14.7%
Q3 25
-49.0%
-5.5%
Q2 25
-14.0%
Q1 25
-16.1%
Q4 24
37.8%
Q3 24
-12.6%
Q2 24
-25.3%
Q1 24
-11.0%
EPS (diluted)
VRDN
VRDN
XPER
XPER
Q4 25
$-0.37
Q3 25
$-0.13
Q2 25
$-0.32
Q1 25
$-0.41
Q4 24
$1.02
Q3 24
$-0.37
Q2 24
$-0.67
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VRDN
VRDN
XPER
XPER
Cash + ST InvestmentsLiquidity on hand
$490.9M
$96.8M
Total DebtLower is stronger
$27.7M
Stockholders' EquityBook value
$503.0M
$414.1M
Total Assets
$577.1M
$615.8M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VRDN
VRDN
XPER
XPER
Q4 25
$96.8M
Q3 25
$490.9M
$96.8M
Q2 25
$95.1M
Q1 25
$88.0M
Q4 24
$130.6M
Q3 24
$72.7M
Q2 24
$92.5M
Q1 24
$95.2M
Total Debt
VRDN
VRDN
XPER
XPER
Q4 25
$27.7M
Q3 25
$27.7M
Q2 25
$27.7M
Q1 25
$27.7M
Q4 24
$27.7M
Q3 24
$27.7M
Q2 24
$27.7M
Q1 24
$27.7M
Stockholders' Equity
VRDN
VRDN
XPER
XPER
Q4 25
$414.1M
Q3 25
$503.0M
$421.0M
Q2 25
$419.8M
Q1 25
$418.9M
Q4 24
$429.1M
Q3 24
$377.4M
Q2 24
$388.7M
Q1 24
$399.1M
Total Assets
VRDN
VRDN
XPER
XPER
Q4 25
$615.8M
Q3 25
$577.1M
$628.8M
Q2 25
$629.2M
Q1 25
$633.5M
Q4 24
$667.8M
Q3 24
$616.2M
Q2 24
$619.2M
Q1 24
$630.4M
Debt / Equity
VRDN
VRDN
XPER
XPER
Q4 25
0.07×
Q3 25
0.07×
Q2 25
0.07×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.07×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VRDN
VRDN
XPER
XPER
Operating Cash FlowLast quarter
$-84.6M
$4.1M
Free Cash FlowOCF − Capex
$-84.7M
$1.2M
FCF MarginFCF / Revenue
-120.1%
1.0%
Capex IntensityCapex / Revenue
0.2%
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VRDN
VRDN
XPER
XPER
Q4 25
$4.1M
Q3 25
$-84.6M
$7.5M
Q2 25
$10.1M
Q1 25
$-22.3M
Q4 24
$1.2M
Q3 24
$-4.6M
Q2 24
$-2.1M
Q1 24
$-49.8M
Free Cash Flow
VRDN
VRDN
XPER
XPER
Q4 25
$1.2M
Q3 25
$-84.7M
$6.7M
Q2 25
$9.5M
Q1 25
$-23.3M
Q4 24
$-510.0K
Q3 24
$-5.6M
Q2 24
$-2.6M
Q1 24
$-51.6M
FCF Margin
VRDN
VRDN
XPER
XPER
Q4 25
1.0%
Q3 25
-120.1%
6.0%
Q2 25
9.0%
Q1 25
-20.5%
Q4 24
-0.4%
Q3 24
-4.2%
Q2 24
-2.2%
Q1 24
-43.4%
Capex Intensity
VRDN
VRDN
XPER
XPER
Q4 25
2.5%
Q3 25
0.2%
0.7%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
1.4%
Q3 24
0.8%
Q2 24
0.4%
Q1 24
1.6%
Cash Conversion
VRDN
VRDN
XPER
XPER
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

VRDN
VRDN

Segment breakdown not available.

XPER
XPER

Pay TV$56.2M48%
Connected Car$31.3M27%
Consumer Electronics$17.2M15%
Media Platform$11.8M10%

Related Comparisons